|
Market Closed -
Nasdaq
00:00:00 05/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 16.88 USD | -0.35% |
|
+3.30% | +35.58% |
| 09-03 | US FDA is working with manufacturers to boost estrogen patch supply amid access concerns | RE |
| 08-28 | Shield Therapeutics to Take Over US Commercialization of ACCRUFeR | MT |
| Market Cap | 19.46B 16.74B 15.75B 14.39B 26.92B 1,837B 26.99B 186B 72.23B 943B 73.06B 71.47B 3,036B | P/E 2026 * |
80.4x | P/E 2027 * | 31.9x |
|---|---|---|---|---|---|
| Enterprise Value | 31.52B 27.12B 25.52B 23.31B 43.61B 2,976B 43.73B 302B 117B 1,527B 118B 116B 4,919B | EV / Sales 2026 * |
2.13x | EV / Sales 2027 * | 2.03x |
| Free-Float |
91.44% | Yield 2026 * |
3% | Yield 2027 * | 3.08% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| VTRS | Delayed | |
CBOE
| VTRS | Real-time | |
|
Xetra
| VIA | Delayed | |
|
Boerse Muenchen
| VIA | Real-time | |
|
Wiener Boerse
| VTRS | End-of-day quote | |
|
Tradegate
| VIA | Real-time | |
|
Mexican S.E.
| VTRS * | End-of-day quote | |
|
Deutsche Boerse AG
| VIA | Delayed | |
|
London S.E.
| 0A5V | Delayed | |
|
Börse Stuttgart
| VIA | Delayed | |
|
Borsa Italiana
| 1VTRS | End-of-day quote | |
|
Swiss Exchange
| VTRS | Delayed | |
|
Swiss Exchange
| VTRS | Delayed | |
|
CBOE
| 0A5V | Real-time | |
|
CBOE
| Real-time |
Last Transcript : Viatris Inc.
| 1 day | -0.35% | ||
| 1 week | +3.30% | ||
| Current month | +2.24% | ||
| 1 month | -4.63% | ||
| 3 months | +6.16% | ||
| 6 months | +14.75% | ||
| Current year | +35.58% |
| 1 week | 16.12 |  | 17.28 |
| 1 month | 15.88 | | 18.39 |
| Current year | 12.19 | | 18.39 |
| 1 year | 9.42 | | 18.39 |
| 3 years | 6.85 | | 18.39 |
| 5 years | 6.85 | | 18.39 |
| 10 years | 6.85 | | 47.82 |
| Manager | Title | Age | Since |
|---|---|---|---|
Scott Smith
CEO | Chief Executive Officer | 63 | 01/04/2023 |
Paul Campbell
DFI | Director of Finance/CFO | 59 | 08/05/2026 |
Philippe Martin
CTO | Chief Tech/Sci/R&D Officer | - | 15/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Wyllie Cornwell
BRD | Director/Board Member | 78 | 16/11/2020 |
James Kilts
BRD | Director/Board Member | 78 | 16/11/2020 |
JoEllen Dillon
BRD | Director/Board Member | 62 | 16/11/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 15/08/26 | Exercice | Chief Administrative Officer | 63,631 | 0.0054% | ||
| 30/06/26 | Free | Director | 2,756 | 0.0002% | ||
| 30/06/26 | Free | Director | 2,362 | 0.0002% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.35% | +3.30% | +63.41% | +58.95% | 19.46B | |
| -0.88% | -2.15% | +54.71% | +105.91% | 1,034B | |
| -1.15% | +2.68% | +53.97% | +71.29% | 671B | |
| -1.44% | +0.38% | +20.40% | +75.54% | 460B | |
| +0.14% | -1.92% | +32.47% | +37.60% | 353B | |
| -1.33% | +3.96% | +25.71% | +45.03% | 309B | |
| -1.15% | -0.89% | -1.67% | +12.21% | 255B | |
| -1.55% | +1.11% | +56.10% | +72.13% | 240B | |
| -0.88% | +1.24% | -18.03% | -54.06% | 207B | |
| -0.15% | +3.65% | +33.90% | +100.90% | 188B | |
| Average | -0.72% | +1.17% | +32.10% | +52.55% | 373.62B | |
| Weighted average by Cap. | -0.84% | +1.04% | +37.06% | +66.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14.78B 12.72B 11.97B 10.93B 20.45B 1,396B 20.51B 141B 54.88B 716B 55.51B 54.3B 2,307B | 15.03B 12.93B 12.17B 11.11B 20.79B 1,419B 20.85B 144B 55.79B 728B 56.43B 55.2B 2,345B |
| Net income | -27.26M -23.46M -22.07M -20.16M -37.71M -2.57B -37.81M -261M -101M -1.32B -102M -100M -4.25B | 340M 292M 275M 251M 470M 32.09B 471M 3.25B 1.26B 16.46B 1.28B 1.25B 53.04B |
| Net Debt | 12.07B 10.38B 9.77B 8.92B 16.69B 1,139B 16.74B 115B 44.79B 584B 45.31B 44.32B 1,883B | 11.08B 9.53B 8.97B 8.19B 15.33B 1,046B 15.37B 106B 41.13B 537B 41.6B 40.69B 1,729B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/09/26 | $16.88 | -0.35% | 5,596,320 |
| 03/09/26 | $16.94 | -0.88% | 8,032,034 |
| 02/09/26 | $17.09 | +2.77% | 7,834,481 |
| 01/09/26 | $16.63 | +0.73% | 6,527,492 |
| 31/08/26 | $16.51 | +1.04% | 12,669,710 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VTRS Stock
Select your edition
All financial news and data tailored to specific country editions
